Creative Planning

Position in INVA — Innoviva, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in INVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$4,421,682

+$2,563,041 QoQ

Shares Held

194,702

+144.1% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#55

of 307 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. INVA ranks #29 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,421,682	194,702	+144.1%	Shares	Defined	2026-08-13
2026-03-31	$1,858,641	79,770	+13.8%	Shares	Sole	2026-05-12
2025-12-31	$1,401,518	70,111	+14.3%	Shares	Sole	2026-02-17
2025-09-30	$1,119,911	61,365	+0.8%	Shares	Sole	2025-11-14
2025-06-30	$1,223,561	60,904	+121.8%	Shares	Defined	2025-08-08
2025-03-31	$497,777	27,456	-3.9%	Shares	Sole	2025-05-15
2024-12-31	$495,446	28,556	+6.6%	Shares	Defined	2025-02-14
2024-09-30	$517,120	26,780	+21.1%	Shares	Defined	2024-10-11
2024-06-30	$362,620	22,111	+14.9%	Shares	Sole	2024-08-15
2024-03-31	$293,202	19,239	+1.4%	Shares	Sole	2024-05-13
2023-12-31	$304,246	18,968	+8.1%	Shares	Sole	2024-02-14
2023-09-30	$227,948	17,548	+9.1%	Shares	Sole	2023-11-16
2023-06-30	$204,838	16,091	—	Shares	Sole	2023-07-21
No filing history on record for this holder in this stock.